nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Cyclobenzaprine—Benzphetamine—obesity	0.36	1	CrCrCtD
Olopatadine—CYP3A4—Sibutramine—obesity	0.0496	0.27	CbGbCtD
Olopatadine—CYP3A4—Benzphetamine—obesity	0.0376	0.204	CbGbCtD
Olopatadine—CYP3A4—Bupropion—obesity	0.032	0.174	CbGbCtD
Olopatadine—CYP3A4—Orlistat—obesity	0.0261	0.142	CbGbCtD
Olopatadine—CYP3A4—Cimetidine—obesity	0.0235	0.127	CbGbCtD
Olopatadine—CYP3A4—Topiramate—obesity	0.0154	0.0835	CbGbCtD
Olopatadine—S100B—hindbrain—obesity	0.00807	0.0649	CbGeAlD
Olopatadine—S100A13—Etomidate—Diethylpropion—obesity	0.00661	1	CbGdCrCtD
Olopatadine—S100A2—islet of Langerhans—obesity	0.00656	0.0528	CbGeAlD
Olopatadine—S100A2—respiratory system—obesity	0.00619	0.0498	CbGeAlD
Olopatadine—S100A13—respiratory system—obesity	0.00506	0.0407	CbGeAlD
Olopatadine—S100A12—respiratory system—obesity	0.00499	0.0402	CbGeAlD
Olopatadine—S100A1—adrenal cortex—obesity	0.00479	0.0385	CbGeAlD
Olopatadine—S100A1—cardiovascular system—obesity	0.00437	0.0351	CbGeAlD
Olopatadine—S100A2—pituitary gland—obesity	0.0042	0.0338	CbGeAlD
Olopatadine—S100A2—adipose tissue—obesity	0.00418	0.0336	CbGeAlD
Olopatadine—S100A13—cardiovascular system—obesity	0.00388	0.0312	CbGeAlD
Olopatadine—S100A1—pituitary gland—obesity	0.00387	0.0311	CbGeAlD
Olopatadine—S100A1—adipose tissue—obesity	0.00385	0.031	CbGeAlD
Olopatadine—S100A12—cardiovascular system—obesity	0.00382	0.0308	CbGeAlD
Olopatadine—S100B—cardiovascular system—obesity	0.00377	0.0304	CbGeAlD
Olopatadine—S100A1—digestive system—obesity	0.00363	0.0292	CbGeAlD
Olopatadine—S100A1—adrenal gland—obesity	0.00346	0.0278	CbGeAlD
Olopatadine—S100A13—adipose tissue—obesity	0.00342	0.0275	CbGeAlD
Olopatadine—S100A12—pituitary gland—obesity	0.00339	0.0272	CbGeAlD
Olopatadine—S100A12—adipose tissue—obesity	0.00337	0.0271	CbGeAlD
Olopatadine—S100B—adipose tissue—obesity	0.00333	0.0268	CbGeAlD
Olopatadine—S100A2—endocrine gland—obesity	0.00325	0.0262	CbGeAlD
Olopatadine—S100A13—digestive system—obesity	0.00322	0.0259	CbGeAlD
Olopatadine—S100A12—digestive system—obesity	0.00317	0.0255	CbGeAlD
Olopatadine—S100A13—adrenal gland—obesity	0.00307	0.0247	CbGeAlD
Olopatadine—S100A12—adrenal gland—obesity	0.00302	0.0243	CbGeAlD
Olopatadine—S100A1—endocrine gland—obesity	0.003	0.0241	CbGeAlD
Olopatadine—S100A13—endocrine gland—obesity	0.00266	0.0214	CbGeAlD
Olopatadine—S100A12—endocrine gland—obesity	0.00262	0.0211	CbGeAlD
Olopatadine—S100B—endocrine gland—obesity	0.00259	0.0208	CbGeAlD
Olopatadine—S100A13—liver—obesity	0.0024	0.0193	CbGeAlD
Olopatadine—S100A12—liver—obesity	0.00236	0.019	CbGeAlD
Olopatadine—HRH1—respiratory system—obesity	0.00101	0.00813	CbGeAlD
Olopatadine—Discomfort—Diethylpropion—obesity	0.000868	0.00456	CcSEcCtD
Olopatadine—Dizziness—Benzphetamine—obesity	0.000859	0.00451	CcSEcCtD
Olopatadine—Dry mouth—Diethylpropion—obesity	0.000859	0.00451	CcSEcCtD
Olopatadine—Headache—Methamphetamine—obesity	0.000844	0.00443	CcSEcCtD
Olopatadine—Eye pain—Bupropion—obesity	0.000841	0.00442	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Phentermine—obesity	0.000835	0.00439	CcSEcCtD
Olopatadine—Mydriasis—Topiramate—obesity	0.000835	0.00439	CcSEcCtD
Olopatadine—Fatigue—Phentermine—obesity	0.000834	0.00438	CcSEcCtD
Olopatadine—Feeling abnormal—Phenylpropanolamine—obesity	0.000833	0.00438	CcSEcCtD
Olopatadine—Dry skin—Orlistat—obesity	0.000825	0.00433	CcSEcCtD
Olopatadine—Headache—Benzphetamine—obesity	0.000814	0.00427	CcSEcCtD
Olopatadine—Diarrhoea—Phendimetrazine—obesity	0.00081	0.00426	CcSEcCtD
Olopatadine—Visual disturbance—Bupropion—obesity	0.000801	0.00421	CcSEcCtD
Olopatadine—Dry skin—Sibutramine—obesity	0.000798	0.00419	CcSEcCtD
Olopatadine—Thirst—Bupropion—obesity	0.000798	0.00419	CcSEcCtD
Olopatadine—Dizziness—Phendimetrazine—obesity	0.000783	0.00411	CcSEcCtD
Olopatadine—Influenza—Orlistat—obesity	0.000778	0.00409	CcSEcCtD
Olopatadine—Nausea—Benzphetamine—obesity	0.000771	0.00405	CcSEcCtD
Olopatadine—Abdominal pain—Phentermine—obesity	0.000765	0.00402	CcSEcCtD
Olopatadine—Influenza—Sibutramine—obesity	0.000753	0.00395	CcSEcCtD
Olopatadine—Dyspnoea—Diethylpropion—obesity	0.000751	0.00394	CcSEcCtD
Olopatadine—Somnolence—Diethylpropion—obesity	0.000748	0.00393	CcSEcCtD
Olopatadine—Hypersensitivity—Phenylpropanolamine—obesity	0.000745	0.00391	CcSEcCtD
Olopatadine—Headache—Phendimetrazine—obesity	0.000742	0.0039	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Diethylpropion—obesity	0.000727	0.00382	CcSEcCtD
Olopatadine—Lacrimation increased—Topiramate—obesity	0.000723	0.0038	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Orlistat—obesity	0.000723	0.0038	CcSEcCtD
Olopatadine—Somnolence—Cimetidine—obesity	0.000712	0.00374	CcSEcCtD
Olopatadine—Nausea—Phendimetrazine—obesity	0.000703	0.00369	CcSEcCtD
Olopatadine—Dry skin—Bupropion—obesity	0.000696	0.00366	CcSEcCtD
Olopatadine—Asthenia—Phentermine—obesity	0.000694	0.00365	CcSEcCtD
Olopatadine—Feeling abnormal—Diethylpropion—obesity	0.000694	0.00364	CcSEcCtD
Olopatadine—Infestation NOS—Orlistat—obesity	0.000693	0.00364	CcSEcCtD
Olopatadine—Infestation—Orlistat—obesity	0.000693	0.00364	CcSEcCtD
Olopatadine—Depression—Orlistat—obesity	0.000691	0.00363	CcSEcCtD
Olopatadine—Fatigue—Cimetidine—obesity	0.000691	0.00363	CcSEcCtD
Olopatadine—Weight increased—Sibutramine—obesity	0.000685	0.0036	CcSEcCtD
Olopatadine—HRH1—adipose tissue—obesity	0.000682	0.00549	CbGeAlD
Olopatadine—Nasopharyngitis—Bupropion—obesity	0.000679	0.00357	CcSEcCtD
Olopatadine—Urinary tract infection—Orlistat—obesity	0.000674	0.00354	CcSEcCtD
Olopatadine—Depression—Sibutramine—obesity	0.000669	0.00352	CcSEcCtD
Olopatadine—Dizziness—Phenylpropanolamine—obesity	0.000669	0.00351	CcSEcCtD
Olopatadine—Diarrhoea—Phentermine—obesity	0.000662	0.00348	CcSEcCtD
Olopatadine—Feeling abnormal—Cimetidine—obesity	0.00066	0.00347	CcSEcCtD
Olopatadine—Influenza—Bupropion—obesity	0.000656	0.00345	CcSEcCtD
Olopatadine—Urinary tract infection—Sibutramine—obesity	0.000652	0.00343	CcSEcCtD
Olopatadine—Conjunctivitis—Sibutramine—obesity	0.000652	0.00343	CcSEcCtD
Olopatadine—Sinusitis—Orlistat—obesity	0.000651	0.00342	CcSEcCtD
Olopatadine—Amitriptyline—NTRK2—obesity	0.000646	0.084	CrCbGaD
Olopatadine—Vomiting—Phenylpropanolamine—obesity	0.000643	0.00338	CcSEcCtD
Olopatadine—HRH1—digestive system—obesity	0.000642	0.00517	CbGeAlD
Olopatadine—Dizziness—Phentermine—obesity	0.00064	0.00336	CcSEcCtD
Olopatadine—Rash—Phenylpropanolamine—obesity	0.000638	0.00335	CcSEcCtD
Olopatadine—Dermatitis—Phenylpropanolamine—obesity	0.000637	0.00335	CcSEcCtD
Olopatadine—Body temperature increased—Cimetidine—obesity	0.000633	0.00333	CcSEcCtD
Olopatadine—Epistaxis—Sibutramine—obesity	0.000633	0.00333	CcSEcCtD
Olopatadine—Sinusitis—Sibutramine—obesity	0.00063	0.00331	CcSEcCtD
Olopatadine—Photophobia—Topiramate—obesity	0.000626	0.00329	CcSEcCtD
Olopatadine—Pharyngitis—Orlistat—obesity	0.000618	0.00325	CcSEcCtD
Olopatadine—Dry eye—Topiramate—obesity	0.000615	0.00323	CcSEcCtD
Olopatadine—Vomiting—Phentermine—obesity	0.000615	0.00323	CcSEcCtD
Olopatadine—HRH1—adrenal gland—obesity	0.000612	0.00492	CbGeAlD
Olopatadine—Rash—Phentermine—obesity	0.00061	0.00321	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Bupropion—obesity	0.00061	0.0032	CcSEcCtD
Olopatadine—Dermatitis—Phentermine—obesity	0.00061	0.0032	CcSEcCtD
Olopatadine—Headache—Phentermine—obesity	0.000606	0.00319	CcSEcCtD
Olopatadine—Rhinitis—Sibutramine—obesity	0.000604	0.00317	CcSEcCtD
Olopatadine—Nausea—Phenylpropanolamine—obesity	0.000601	0.00316	CcSEcCtD
Olopatadine—Hypoaesthesia—Sibutramine—obesity	0.000599	0.00315	CcSEcCtD
Olopatadine—Pharyngitis—Sibutramine—obesity	0.000598	0.00314	CcSEcCtD
Olopatadine—Weight increased—Bupropion—obesity	0.000597	0.00314	CcSEcCtD
Olopatadine—Hypersensitivity—Cimetidine—obesity	0.00059	0.0031	CcSEcCtD
Olopatadine—Infestation NOS—Bupropion—obesity	0.000585	0.00307	CcSEcCtD
Olopatadine—Infestation—Bupropion—obesity	0.000585	0.00307	CcSEcCtD
Olopatadine—Visual impairment—Sibutramine—obesity	0.000581	0.00305	CcSEcCtD
Olopatadine—Diarrhoea—Diethylpropion—obesity	0.000576	0.00303	CcSEcCtD
Olopatadine—Nausea—Phentermine—obesity	0.000575	0.00302	CcSEcCtD
Olopatadine—Asthenia—Cimetidine—obesity	0.000575	0.00302	CcSEcCtD
Olopatadine—Urinary tract infection—Bupropion—obesity	0.000569	0.00299	CcSEcCtD
Olopatadine—Conjunctivitis—Bupropion—obesity	0.000569	0.00299	CcSEcCtD
Olopatadine—Eye disorder—Sibutramine—obesity	0.000563	0.00296	CcSEcCtD
Olopatadine—Immune system disorder—Orlistat—obesity	0.000562	0.00295	CcSEcCtD
Olopatadine—Mediastinal disorder—Orlistat—obesity	0.000561	0.00295	CcSEcCtD
Olopatadine—Dizziness—Diethylpropion—obesity	0.000557	0.00292	CcSEcCtD
Olopatadine—Epistaxis—Bupropion—obesity	0.000552	0.0029	CcSEcCtD
Olopatadine—Sinusitis—Bupropion—obesity	0.000549	0.00288	CcSEcCtD
Olopatadine—Diarrhoea—Cimetidine—obesity	0.000548	0.00288	CcSEcCtD
Olopatadine—Immune system disorder—Sibutramine—obesity	0.000544	0.00286	CcSEcCtD
Olopatadine—Eye pain—Topiramate—obesity	0.000536	0.00281	CcSEcCtD
Olopatadine—Vomiting—Diethylpropion—obesity	0.000535	0.00281	CcSEcCtD
Olopatadine—HRH1—endocrine gland—obesity	0.000531	0.00427	CbGeAlD
Olopatadine—Rash—Diethylpropion—obesity	0.000531	0.00279	CcSEcCtD
Olopatadine—Dysgeusia—Orlistat—obesity	0.000531	0.00279	CcSEcCtD
Olopatadine—Dermatitis—Diethylpropion—obesity	0.00053	0.00279	CcSEcCtD
Olopatadine—Dizziness—Cimetidine—obesity	0.00053	0.00278	CcSEcCtD
Olopatadine—Headache—Diethylpropion—obesity	0.000527	0.00277	CcSEcCtD
Olopatadine—Rhinitis—Bupropion—obesity	0.000526	0.00277	CcSEcCtD
Olopatadine—Back pain—Orlistat—obesity	0.000524	0.00275	CcSEcCtD
Olopatadine—Hypoaesthesia—Bupropion—obesity	0.000523	0.00275	CcSEcCtD
Olopatadine—Pharyngitis—Bupropion—obesity	0.000521	0.00274	CcSEcCtD
Olopatadine—Muscle spasms—Orlistat—obesity	0.000521	0.00274	CcSEcCtD
Olopatadine—Dysgeusia—Sibutramine—obesity	0.000514	0.0027	CcSEcCtD
Olopatadine—Vision blurred—Orlistat—obesity	0.000511	0.00268	CcSEcCtD
Olopatadine—Visual disturbance—Topiramate—obesity	0.00051	0.00268	CcSEcCtD
Olopatadine—Vomiting—Cimetidine—obesity	0.000509	0.00268	CcSEcCtD
Olopatadine—Thirst—Topiramate—obesity	0.000508	0.00267	CcSEcCtD
Olopatadine—Back pain—Sibutramine—obesity	0.000507	0.00267	CcSEcCtD
Olopatadine—Visual impairment—Bupropion—obesity	0.000506	0.00266	CcSEcCtD
Olopatadine—Rash—Cimetidine—obesity	0.000505	0.00265	CcSEcCtD
Olopatadine—Dermatitis—Cimetidine—obesity	0.000505	0.00265	CcSEcCtD
Olopatadine—Muscle spasms—Sibutramine—obesity	0.000504	0.00265	CcSEcCtD
Olopatadine—Ill-defined disorder—Orlistat—obesity	0.000503	0.00264	CcSEcCtD
Olopatadine—Headache—Cimetidine—obesity	0.000502	0.00264	CcSEcCtD
Olopatadine—Nausea—Diethylpropion—obesity	0.0005	0.00263	CcSEcCtD
Olopatadine—CYP3A4—digestive system—obesity	0.000497	0.004	CbGeAlD
Olopatadine—Vision blurred—Sibutramine—obesity	0.000494	0.0026	CcSEcCtD
Olopatadine—Eye disorder—Bupropion—obesity	0.000491	0.00258	CcSEcCtD
Olopatadine—Malaise—Orlistat—obesity	0.000489	0.00257	CcSEcCtD
Olopatadine—Ill-defined disorder—Sibutramine—obesity	0.000487	0.00256	CcSEcCtD
Olopatadine—Nausea—Cimetidine—obesity	0.000476	0.0025	CcSEcCtD
Olopatadine—Immune system disorder—Bupropion—obesity	0.000474	0.00249	CcSEcCtD
Olopatadine—Mediastinal disorder—Bupropion—obesity	0.000473	0.00249	CcSEcCtD
Olopatadine—Malaise—Sibutramine—obesity	0.000473	0.00248	CcSEcCtD
Olopatadine—Cough—Orlistat—obesity	0.000473	0.00248	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000458	0.00241	CcSEcCtD
Olopatadine—Cough—Sibutramine—obesity	0.000458	0.0024	CcSEcCtD
Olopatadine—Discomfort—Orlistat—obesity	0.000456	0.00239	CcSEcCtD
Olopatadine—Dry mouth—Orlistat—obesity	0.000451	0.00237	CcSEcCtD
Olopatadine—Dysgeusia—Bupropion—obesity	0.000448	0.00235	CcSEcCtD
Olopatadine—Oedema—Orlistat—obesity	0.000442	0.00232	CcSEcCtD
Olopatadine—Back pain—Bupropion—obesity	0.000442	0.00232	CcSEcCtD
Olopatadine—Discomfort—Sibutramine—obesity	0.000441	0.00232	CcSEcCtD
Olopatadine—Muscle spasms—Bupropion—obesity	0.00044	0.00231	CcSEcCtD
Olopatadine—Infection—Orlistat—obesity	0.000439	0.00231	CcSEcCtD
Olopatadine—Dry mouth—Sibutramine—obesity	0.000437	0.00229	CcSEcCtD
Olopatadine—Nervous system disorder—Orlistat—obesity	0.000434	0.00228	CcSEcCtD
Olopatadine—Nasopharyngitis—Topiramate—obesity	0.000432	0.00227	CcSEcCtD
Olopatadine—Vision blurred—Bupropion—obesity	0.000431	0.00226	CcSEcCtD
Olopatadine—Skin disorder—Orlistat—obesity	0.00043	0.00226	CcSEcCtD
Olopatadine—Oedema—Sibutramine—obesity	0.000428	0.00225	CcSEcCtD
Olopatadine—Infection—Sibutramine—obesity	0.000425	0.00223	CcSEcCtD
Olopatadine—Ill-defined disorder—Bupropion—obesity	0.000424	0.00223	CcSEcCtD
Olopatadine—Skin disorder—Sibutramine—obesity	0.000416	0.00218	CcSEcCtD
Olopatadine—Malaise—Bupropion—obesity	0.000412	0.00217	CcSEcCtD
Olopatadine—CYP3A4—endocrine gland—obesity	0.00041	0.0033	CbGeAlD
Olopatadine—Cough—Bupropion—obesity	0.000399	0.0021	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Topiramate—obesity	0.000388	0.00204	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000387	0.00203	CcSEcCtD
Olopatadine—Discomfort—Bupropion—obesity	0.000385	0.00202	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Orlistat—obesity	0.000382	0.00201	CcSEcCtD
Olopatadine—Dyspnoea—Sibutramine—obesity	0.000382	0.002	CcSEcCtD
Olopatadine—Fatigue—Orlistat—obesity	0.000381	0.002	CcSEcCtD
Olopatadine—Dry mouth—Bupropion—obesity	0.000381	0.002	CcSEcCtD
Olopatadine—Somnolence—Sibutramine—obesity	0.00038	0.002	CcSEcCtD
Olopatadine—Weight increased—Topiramate—obesity	0.00038	0.002	CcSEcCtD
Olopatadine—Pain—Orlistat—obesity	0.000378	0.00199	CcSEcCtD
Olopatadine—Oedema—Bupropion—obesity	0.000373	0.00196	CcSEcCtD
Olopatadine—Acepromazine—SLC22A1—obesity	0.000373	0.0485	CrCbGaD
Olopatadine—Infestation—Topiramate—obesity	0.000373	0.00196	CcSEcCtD
Olopatadine—Infestation NOS—Topiramate—obesity	0.000373	0.00196	CcSEcCtD
Olopatadine—Depression—Topiramate—obesity	0.000372	0.00195	CcSEcCtD
Olopatadine—Infection—Bupropion—obesity	0.000371	0.00195	CcSEcCtD
Olopatadine—CYP3A4—liver—obesity	0.00037	0.00298	CbGeAlD
Olopatadine—Gastrointestinal disorder—Sibutramine—obesity	0.000369	0.00194	CcSEcCtD
Olopatadine—Pain—Sibutramine—obesity	0.000366	0.00192	CcSEcCtD
Olopatadine—Nervous system disorder—Bupropion—obesity	0.000366	0.00192	CcSEcCtD
Olopatadine—Feeling abnormal—Orlistat—obesity	0.000364	0.00191	CcSEcCtD
Olopatadine—Skin disorder—Bupropion—obesity	0.000362	0.0019	CcSEcCtD
Olopatadine—Conjunctivitis—Topiramate—obesity	0.000362	0.0019	CcSEcCtD
Olopatadine—Urinary tract infection—Topiramate—obesity	0.000362	0.0019	CcSEcCtD
Olopatadine—Gastrointestinal pain—Orlistat—obesity	0.000362	0.0019	CcSEcCtD
Olopatadine—Thiothixene—SLC22A1—obesity	0.000359	0.0466	CrCbGaD
Olopatadine—Feeling abnormal—Sibutramine—obesity	0.000353	0.00185	CcSEcCtD
Olopatadine—Epistaxis—Topiramate—obesity	0.000352	0.00185	CcSEcCtD
Olopatadine—Gastrointestinal pain—Sibutramine—obesity	0.00035	0.00184	CcSEcCtD
Olopatadine—Sinusitis—Topiramate—obesity	0.00035	0.00184	CcSEcCtD
Olopatadine—Abdominal pain—Orlistat—obesity	0.00035	0.00184	CcSEcCtD
Olopatadine—Body temperature increased—Orlistat—obesity	0.00035	0.00184	CcSEcCtD
Olopatadine—Body temperature increased—Sibutramine—obesity	0.000338	0.00178	CcSEcCtD
Olopatadine—Abdominal pain—Sibutramine—obesity	0.000338	0.00178	CcSEcCtD
Olopatadine—Rhinitis—Topiramate—obesity	0.000335	0.00176	CcSEcCtD
Olopatadine—Hypoaesthesia—Topiramate—obesity	0.000333	0.00175	CcSEcCtD
Olopatadine—Dyspnoea—Bupropion—obesity	0.000333	0.00175	CcSEcCtD
Olopatadine—Pharyngitis—Topiramate—obesity	0.000332	0.00174	CcSEcCtD
Olopatadine—Somnolence—Bupropion—obesity	0.000332	0.00174	CcSEcCtD
Olopatadine—Hypersensitivity—Orlistat—obesity	0.000326	0.00171	CcSEcCtD
Olopatadine—Visual impairment—Topiramate—obesity	0.000322	0.00169	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Bupropion—obesity	0.000322	0.00169	CcSEcCtD
Olopatadine—Fatigue—Bupropion—obesity	0.000322	0.00169	CcSEcCtD
Olopatadine—Pain—Bupropion—obesity	0.000319	0.00168	CcSEcCtD
Olopatadine—Asthenia—Orlistat—obesity	0.000317	0.00167	CcSEcCtD
Olopatadine—Hypersensitivity—Sibutramine—obesity	0.000315	0.00166	CcSEcCtD
Olopatadine—Pruritus—Orlistat—obesity	0.000313	0.00164	CcSEcCtD
Olopatadine—Eye disorder—Topiramate—obesity	0.000313	0.00164	CcSEcCtD
Olopatadine—Feeling abnormal—Bupropion—obesity	0.000307	0.00162	CcSEcCtD
Olopatadine—Asthenia—Sibutramine—obesity	0.000307	0.00161	CcSEcCtD
Olopatadine—Gastrointestinal pain—Bupropion—obesity	0.000305	0.0016	CcSEcCtD
Olopatadine—Acepromazine—DRD1—obesity	0.000305	0.0396	CrCbGaD
Olopatadine—Pruritus—Sibutramine—obesity	0.000303	0.00159	CcSEcCtD
Olopatadine—Diarrhoea—Orlistat—obesity	0.000303	0.00159	CcSEcCtD
Olopatadine—Immune system disorder—Topiramate—obesity	0.000302	0.00159	CcSEcCtD
Olopatadine—Mediastinal disorder—Topiramate—obesity	0.000302	0.00158	CcSEcCtD
Olopatadine—Abdominal pain—Bupropion—obesity	0.000295	0.00155	CcSEcCtD
Olopatadine—Body temperature increased—Bupropion—obesity	0.000295	0.00155	CcSEcCtD
Olopatadine—Thiothixene—DRD1—obesity	0.000293	0.0381	CrCbGaD
Olopatadine—Diarrhoea—Sibutramine—obesity	0.000293	0.00154	CcSEcCtD
Olopatadine—Dizziness—Orlistat—obesity	0.000292	0.00154	CcSEcCtD
Olopatadine—Erythema—Topiramate—obesity	0.000291	0.00153	CcSEcCtD
Olopatadine—Dysgeusia—Topiramate—obesity	0.000285	0.0015	CcSEcCtD
Olopatadine—Dizziness—Sibutramine—obesity	0.000283	0.00149	CcSEcCtD
Olopatadine—Back pain—Topiramate—obesity	0.000282	0.00148	CcSEcCtD
Olopatadine—Vomiting—Orlistat—obesity	0.000281	0.00148	CcSEcCtD
Olopatadine—Muscle spasms—Topiramate—obesity	0.00028	0.00147	CcSEcCtD
Olopatadine—Rash—Orlistat—obesity	0.000279	0.00146	CcSEcCtD
Olopatadine—Dermatitis—Orlistat—obesity	0.000279	0.00146	CcSEcCtD
Olopatadine—Headache—Orlistat—obesity	0.000277	0.00146	CcSEcCtD
Olopatadine—Hypersensitivity—Bupropion—obesity	0.000275	0.00144	CcSEcCtD
Olopatadine—Vision blurred—Topiramate—obesity	0.000274	0.00144	CcSEcCtD
Olopatadine—Vomiting—Sibutramine—obesity	0.000272	0.00143	CcSEcCtD
Olopatadine—Ill-defined disorder—Topiramate—obesity	0.00027	0.00142	CcSEcCtD
Olopatadine—Rash—Sibutramine—obesity	0.00027	0.00142	CcSEcCtD
Olopatadine—Dermatitis—Sibutramine—obesity	0.00027	0.00142	CcSEcCtD
Olopatadine—Headache—Sibutramine—obesity	0.000268	0.00141	CcSEcCtD
Olopatadine—Asthenia—Bupropion—obesity	0.000268	0.00141	CcSEcCtD
Olopatadine—Pruritus—Bupropion—obesity	0.000264	0.00139	CcSEcCtD
Olopatadine—Nausea—Orlistat—obesity	0.000263	0.00138	CcSEcCtD
Olopatadine—Malaise—Topiramate—obesity	0.000263	0.00138	CcSEcCtD
Olopatadine—Diarrhoea—Bupropion—obesity	0.000255	0.00134	CcSEcCtD
Olopatadine—Nausea—Sibutramine—obesity	0.000254	0.00134	CcSEcCtD
Olopatadine—Cough—Topiramate—obesity	0.000254	0.00134	CcSEcCtD
Olopatadine—Thiothixene—HTR2C—obesity	0.000251	0.0326	CrCbGaD
Olopatadine—Dizziness—Bupropion—obesity	0.000247	0.0013	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000246	0.00129	CcSEcCtD
Olopatadine—Discomfort—Topiramate—obesity	0.000245	0.00129	CcSEcCtD
Olopatadine—Dry mouth—Topiramate—obesity	0.000243	0.00127	CcSEcCtD
Olopatadine—Cyclobenzaprine—HTR2A—obesity	0.00024	0.0313	CrCbGaD
Olopatadine—Oedema—Topiramate—obesity	0.000238	0.00125	CcSEcCtD
Olopatadine—Vomiting—Bupropion—obesity	0.000237	0.00125	CcSEcCtD
Olopatadine—Infection—Topiramate—obesity	0.000236	0.00124	CcSEcCtD
Olopatadine—Rash—Bupropion—obesity	0.000235	0.00124	CcSEcCtD
Olopatadine—Dermatitis—Bupropion—obesity	0.000235	0.00123	CcSEcCtD
Olopatadine—Headache—Bupropion—obesity	0.000234	0.00123	CcSEcCtD
Olopatadine—Nervous system disorder—Topiramate—obesity	0.000233	0.00122	CcSEcCtD
Olopatadine—Skin disorder—Topiramate—obesity	0.000231	0.00121	CcSEcCtD
Olopatadine—Chlorprothixene—DRD1—obesity	0.000231	0.03	CrCbGaD
Olopatadine—Nausea—Bupropion—obesity	0.000222	0.00116	CcSEcCtD
Olopatadine—Acepromazine—DRD2—obesity	0.000215	0.0279	CrCbGaD
Olopatadine—Dyspnoea—Topiramate—obesity	0.000212	0.00111	CcSEcCtD
Olopatadine—Somnolence—Topiramate—obesity	0.000211	0.00111	CcSEcCtD
Olopatadine—Thiothixene—DRD2—obesity	0.000207	0.0269	CrCbGaD
Olopatadine—Gastrointestinal disorder—Topiramate—obesity	0.000205	0.00108	CcSEcCtD
Olopatadine—Fatigue—Topiramate—obesity	0.000205	0.00108	CcSEcCtD
Olopatadine—Pain—Topiramate—obesity	0.000203	0.00107	CcSEcCtD
Olopatadine—Clomipramine—HTR2C—obesity	0.000198	0.0258	CrCbGaD
Olopatadine—Chlorprothixene—HTR2C—obesity	0.000197	0.0257	CrCbGaD
Olopatadine—Feeling abnormal—Topiramate—obesity	0.000196	0.00103	CcSEcCtD
Olopatadine—Gastrointestinal pain—Topiramate—obesity	0.000194	0.00102	CcSEcCtD
Olopatadine—Nortriptyline—HTR2C—obesity	0.000194	0.0252	CrCbGaD
Olopatadine—Imipramine—SLC22A1—obesity	0.000193	0.0252	CrCbGaD
Olopatadine—Body temperature increased—Topiramate—obesity	0.000188	0.000987	CcSEcCtD
Olopatadine—Abdominal pain—Topiramate—obesity	0.000188	0.000987	CcSEcCtD
Olopatadine—Hypersensitivity—Topiramate—obesity	0.000175	0.00092	CcSEcCtD
Olopatadine—Doxepin—HTR2C—obesity	0.000174	0.0226	CrCbGaD
Olopatadine—Asthenia—Topiramate—obesity	0.000171	0.000896	CcSEcCtD
Olopatadine—Pruritus—Topiramate—obesity	0.000168	0.000884	CcSEcCtD
Olopatadine—Acepromazine—HTR2A—obesity	0.000166	0.0216	CrCbGaD
Olopatadine—Amitriptyline—HTR1B—obesity	0.000165	0.0214	CrCbGaD
Olopatadine—Clomipramine—SLC6A4—obesity	0.000164	0.0214	CrCbGaD
Olopatadine—Diarrhoea—Topiramate—obesity	0.000163	0.000855	CcSEcCtD
Olopatadine—Chlorprothixene—DRD2—obesity	0.000163	0.0212	CrCbGaD
Olopatadine—Nortriptyline—SLC6A4—obesity	0.000161	0.0209	CrCbGaD
Olopatadine—Thiothixene—HTR2A—obesity	0.00016	0.0208	CrCbGaD
Olopatadine—Nortriptyline—DRD2—obesity	0.00016	0.0208	CrCbGaD
Olopatadine—Dizziness—Topiramate—obesity	0.000157	0.000826	CcSEcCtD
Olopatadine—Nortriptyline—CYP2E1—obesity	0.000154	0.02	CrCbGaD
Olopatadine—Vomiting—Topiramate—obesity	0.000151	0.000794	CcSEcCtD
Olopatadine—Rash—Topiramate—obesity	0.00015	0.000787	CcSEcCtD
Olopatadine—Dermatitis—Topiramate—obesity	0.00015	0.000787	CcSEcCtD
Olopatadine—Headache—Topiramate—obesity	0.000149	0.000782	CcSEcCtD
Olopatadine—Doxepin—SLC6A4—obesity	0.000144	0.0187	CrCbGaD
Olopatadine—Doxepin—DRD2—obesity	0.000143	0.0186	CrCbGaD
Olopatadine—Nausea—Topiramate—obesity	0.000141	0.000742	CcSEcCtD
Olopatadine—Imipramine—HTR2C—obesity	0.000135	0.0176	CrCbGaD
Olopatadine—Amitriptyline—HTR2C—obesity	0.000134	0.0175	CrCbGaD
Olopatadine—Clomipramine—HTR2A—obesity	0.000126	0.0164	CrCbGaD
Olopatadine—Chlorprothixene—HTR2A—obesity	0.000126	0.0163	CrCbGaD
Olopatadine—Nortriptyline—HTR2A—obesity	0.000123	0.016	CrCbGaD
Olopatadine—Acepromazine—ALB—obesity	0.000114	0.0148	CrCbGaD
Olopatadine—Imipramine—SLC6A4—obesity	0.000112	0.0146	CrCbGaD
Olopatadine—Imipramine—DRD2—obesity	0.000111	0.0145	CrCbGaD
Olopatadine—Amitriptyline—SLC6A4—obesity	0.000111	0.0145	CrCbGaD
Olopatadine—Amitriptyline—DRD2—obesity	0.000111	0.0144	CrCbGaD
Olopatadine—Doxepin—HTR2A—obesity	0.000111	0.0144	CrCbGaD
Olopatadine—Thiothixene—ALB—obesity	0.000109	0.0142	CrCbGaD
Olopatadine—Imipramine—CYP2E1—obesity	0.000107	0.014	CrCbGaD
Olopatadine—Amitriptyline—CYP2E1—obesity	0.000107	0.0139	CrCbGaD
Olopatadine—Clomipramine—ALB—obesity	8.64e-05	0.0112	CrCbGaD
Olopatadine—Imipramine—HTR2A—obesity	8.61e-05	0.0112	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—obesity	8.56e-05	0.0111	CrCbGaD
Olopatadine—Nortriptyline—ALB—obesity	8.44e-05	0.011	CrCbGaD
Olopatadine—Amitriptyline—ALB—obesity	5.86e-05	0.00762	CrCbGaD
Olopatadine—S100B—Signaling Pathways—PIK3CB—obesity	2.04e-05	0.000161	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—obesity	2.04e-05	0.00016	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	2.03e-05	0.00016	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C5AR1—obesity	2.03e-05	0.00016	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNB3—obesity	2.01e-05	0.000159	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNAS—obesity	1.96e-05	0.000154	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SUCLG2—obesity	1.93e-05	0.000152	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ME1—obesity	1.93e-05	0.000152	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH6A1—obesity	1.93e-05	0.000152	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—obesity	1.92e-05	0.000152	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—obesity	1.92e-05	0.000152	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—obesity	1.92e-05	0.000151	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL5—obesity	1.87e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCK—obesity	1.86e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKG1—obesity	1.86e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNB3—obesity	1.83e-05	0.000144	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PNPLA3—obesity	1.81e-05	0.000143	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UCP1—obesity	1.81e-05	0.000143	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COX7C—obesity	1.81e-05	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLP1R—obesity	1.81e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP4—obesity	1.81e-05	0.000142	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—obesity	1.8e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	1.8e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNAS—obesity	1.78e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRH3—obesity	1.78e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCKAR—obesity	1.78e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—obesity	1.77e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—obesity	1.73e-05	0.000136	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CPS1—obesity	1.72e-05	0.000136	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DGAT2—obesity	1.72e-05	0.000136	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SUCLA2—obesity	1.72e-05	0.000136	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CS—obesity	1.72e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKAR2B—obesity	1.71e-05	0.000135	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—obesity	1.7e-05	0.000134	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL5—obesity	1.7e-05	0.000134	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCD—obesity	1.69e-05	0.000133	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—obesity	1.66e-05	0.000131	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCF2—obesity	1.65e-05	0.00013	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—obesity	1.65e-05	0.00013	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—C3—obesity	1.65e-05	0.00013	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MUT—obesity	1.64e-05	0.000129	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LIPE—obesity	1.64e-05	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPY—obesity	1.61e-05	0.000127	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOC3—obesity	1.6e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IAPP—obesity	1.6e-05	0.000126	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—obesity	1.58e-05	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYB5A—obesity	1.57e-05	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DGAT1—obesity	1.57e-05	0.000124	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—obesity	1.57e-05	0.000124	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGT—obesity	1.57e-05	0.000124	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CRH—obesity	1.55e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR1B—obesity	1.55e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SDC1—obesity	1.54e-05	0.000121	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCD—obesity	1.53e-05	0.000121	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACLY—obesity	1.51e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKR1C3—obesity	1.51e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—obesity	1.5e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—C3—obesity	1.5e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPS—obesity	1.47e-05	0.000116	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—obesity	1.47e-05	0.000116	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENPP1—obesity	1.46e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALOX12—obesity	1.46e-05	0.000115	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—obesity	1.46e-05	0.000115	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCB—obesity	1.45e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—obesity	1.45e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD1—obesity	1.45e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2C—obesity	1.45e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGT—obesity	1.42e-05	0.000112	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMGCS1—obesity	1.42e-05	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK2—obesity	1.41e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB1—obesity	1.4e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CG—obesity	1.39e-05	0.000109	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PNPLA2—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACADM—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ANGPTL4—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SAT1—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PFKFB3—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLIN1—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GHRL—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PARP1—obesity	1.37e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD4—obesity	1.36e-05	0.000107	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACACB—obesity	1.34e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYTB—obesity	1.34e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—OXCT1—obesity	1.34e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—obesity	1.32e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—obesity	1.32e-05	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCB—obesity	1.32e-05	0.000104	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SRD5A1—obesity	1.3e-05	0.000103	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PNLIP—obesity	1.3e-05	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR1—obesity	1.3e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TCF7L2—obesity	1.27e-05	0.0001	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SDC3—obesity	1.27e-05	0.0001	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT2—obesity	1.27e-05	0.0001	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD2—obesity	1.27e-05	9.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CG—obesity	1.26e-05	9.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GCG—obesity	1.25e-05	9.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTPN1—obesity	1.25e-05	9.88e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—obesity	1.24e-05	9.81e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP26B1—obesity	1.24e-05	9.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HK2—obesity	1.24e-05	9.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STS—obesity	1.24e-05	9.8e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CD—obesity	1.22e-05	9.61e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARD—obesity	1.22e-05	9.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—obesity	1.2e-05	9.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRL—obesity	1.2e-05	9.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC27A1—obesity	1.19e-05	9.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STK11—obesity	1.18e-05	9.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—obesity	1.17e-05	9.24e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLUL—obesity	1.17e-05	9.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FABP4—obesity	1.17e-05	9.21e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLG—obesity	1.17e-05	9.18e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RHOA—obesity	1.16e-05	9.17e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT2—obesity	1.15e-05	9.08e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3R1—obesity	1.15e-05	9.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FOXO3—obesity	1.14e-05	8.96e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—obesity	1.13e-05	8.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS1—obesity	1.12e-05	8.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UCP2—obesity	1.11e-05	8.73e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD11B1—obesity	1.11e-05	8.73e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UCP3—obesity	1.11e-05	8.73e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ECHS1—obesity	1.11e-05	8.73e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CD—obesity	1.11e-05	8.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS3—obesity	1.1e-05	8.69e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—obesity	1.1e-05	8.68e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADH1B—obesity	1.09e-05	8.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNB3—obesity	1.08e-05	8.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACSL1—obesity	1.07e-05	8.46e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARGC1B—obesity	1.07e-05	8.46e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPAM—obesity	1.07e-05	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TYK2—obesity	1.06e-05	8.39e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CB—obesity	1.06e-05	8.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—obesity	1.06e-05	8.36e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RHOA—obesity	1.06e-05	8.32e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNAS—obesity	1.05e-05	8.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3R1—obesity	1.05e-05	8.24e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FADS1—obesity	1.04e-05	8.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PCK1—obesity	1.04e-05	8.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HADH—obesity	1.04e-05	8.21e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOB—obesity	1.03e-05	8.12e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—obesity	1.02e-05	8.01e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACP5—obesity	1.01e-05	7.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL5—obesity	1.01e-05	7.93e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—G6PD—obesity	9.88e-06	7.78e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LPL—obesity	9.83e-06	7.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FOXO1—obesity	9.76e-06	7.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HK1—obesity	9.76e-06	7.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SREBF2—obesity	9.76e-06	7.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RPS6KB1—obesity	9.75e-06	7.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CB—obesity	9.65e-06	7.6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPA—obesity	9.42e-06	7.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPIN1—obesity	9.22e-06	7.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCD—obesity	9.06e-06	7.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA5—obesity	9.03e-06	7.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—obesity	8.87e-06	6.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C3—obesity	8.85e-06	6.98e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CLOCK—obesity	8.62e-06	6.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC22A1—obesity	8.62e-06	6.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS2—obesity	8.42e-06	6.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGT—obesity	8.41e-06	6.63e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SULT2A1—obesity	8.4e-06	6.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLP1R—obesity	8.4e-06	6.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DPYD—obesity	8.26e-06	6.51e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—obesity	8.24e-06	6.5e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—obesity	8.24e-06	6.5e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CAV1—obesity	8.17e-06	6.44e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOA1—obesity	8.15e-06	6.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PRKAR2B—obesity	7.95e-06	6.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DCN—obesity	7.9e-06	6.22e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ESR1—obesity	7.87e-06	6.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—obesity	7.77e-06	6.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCB—obesity	7.77e-06	6.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CPT1A—obesity	7.68e-06	6.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BAD—obesity	7.68e-06	6.05e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAMPT—obesity	7.53e-06	5.94e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCK—obesity	7.49e-06	5.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LIPC—obesity	7.49e-06	5.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOC3—obesity	7.44e-06	5.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CG—obesity	7.44e-06	5.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS1—obesity	7.35e-06	5.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CETP—obesity	7.22e-06	5.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SDC1—obesity	7.14e-06	5.63e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—obesity	7.08e-06	5.58e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—obesity	7.04e-06	5.55e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKR1C3—obesity	7.03e-06	5.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—obesity	6.93e-06	5.46e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SCARB1—obesity	6.92e-06	5.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—obesity	6.81e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT2—obesity	6.81e-06	5.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SREBF1—obesity	6.71e-06	5.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CD—obesity	6.54e-06	5.15e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT2—obesity	6.53e-06	5.15e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—obesity	6.48e-06	5.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—obesity	6.47e-06	5.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FASN—obesity	6.39e-06	5.04e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—obesity	6.36e-06	5.02e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TYK2—obesity	6.29e-06	4.96e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RHOA—obesity	6.24e-06	4.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3R1—obesity	6.18e-06	4.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—obesity	6.18e-06	4.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2E1—obesity	6.14e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NQO1—obesity	6.07e-06	4.79e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—obesity	5.88e-06	4.64e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCG—obesity	5.82e-06	4.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A4—obesity	5.82e-06	4.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYCS—obesity	5.75e-06	4.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTOR—obesity	5.7e-06	4.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CB—obesity	5.7e-06	4.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT1—obesity	5.64e-06	4.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT1—obesity	5.64e-06	4.44e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NCOA1—obesity	5.55e-06	4.38e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP19A1—obesity	5.47e-06	4.31e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STK11—obesity	5.47e-06	4.31e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—obesity	5.29e-06	4.17e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—obesity	5.21e-06	4.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COMT—obesity	5.09e-06	4.01e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GNB3—obesity	5.02e-06	3.95e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARGC1A—obesity	5.02e-06	3.95e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—obesity	4.99e-06	3.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—obesity	4.95e-06	3.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GNAS—obesity	4.89e-06	3.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—obesity	4.82e-06	3.8e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—obesity	4.81e-06	3.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOB—obesity	4.78e-06	3.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPL—obesity	4.57e-06	3.6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX1—obesity	4.46e-06	3.51e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—obesity	4.41e-06	3.47e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD36—obesity	4.34e-06	3.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—obesity	4.11e-06	3.24e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—obesity	4.09e-06	3.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—obesity	4.08e-06	3.22e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARA—obesity	4.04e-06	3.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AGT—obesity	3.91e-06	3.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—obesity	3.83e-06	3.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAV1—obesity	3.79e-06	2.99e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA1—obesity	3.79e-06	2.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—obesity	3.47e-06	2.74e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CG—obesity	3.46e-06	2.72e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—obesity	3.34e-06	2.63e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—obesity	3.29e-06	2.59e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—obesity	3.27e-06	2.58e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—obesity	3.08e-06	2.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CD—obesity	3.04e-06	2.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—obesity	3e-06	2.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—obesity	2.87e-06	2.26e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3R1—obesity	2.87e-06	2.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—obesity	2.84e-06	2.24e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CB—obesity	2.65e-06	2.09e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—obesity	2.62e-06	2.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—obesity	1.61e-06	1.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—obesity	1.32e-06	1.04e-05	CbGpPWpGaD
